Myo-Inositol Trispyrophosphate (ITPP) Sodium is a research compound studied for its role in modulating oxygen release from hemoglobin. Available as 1g powder. For research purposes only.
Buy Myo-Inositol Trispyrophosphate (ITPP) Sodium Powder – 1g | High-Purity Oxygen Modulation Research Compound
Buy ITPP sodium powder — Myo-Inositol Trispyrophosphate (ITPP) is a high-purity 1g research-grade compound studied for its role in modulating oxygen release from hemoglobin. Each batch is tested to 99%+ purity using HPLC analysis and verified with third-party COA documentation.
ITPP is primarily investigated in advanced physiological research models focused on oxygen delivery efficiency, hypoxia tolerance, and metabolic oxygen utilization pathways. Its sodium salt form improves stability and solubility for laboratory applications.
Research Overview
ITPP (Myo-Inositol Trispyrophosphate) is a synthetic allosteric effector of hemoglobin that reduces oxygen affinity, thereby increasing oxygen release in peripheral tissues under controlled research conditions. This mechanism has made it a subject of interest in hypoxia, endurance physiology, and cellular oxygenation studies.
Research models have explored its effects on oxygen transport efficiency, tissue oxygenation under low-oxygen environments, and metabolic adaptation pathways in preclinical systems.
Quality Standards
- 99%+ purity verified via HPLC testing
- Mass spectrometry identity confirmation
- Third-party batch-specific COA
- Heavy metal and microbial screening
- Research-grade laboratory synthesis
Interlinking Resources
- PubMed: ITPP Research Studies
- Inositol Pyrophosphate Scientific Overview
- NIH: Hemoglobin Oxygen Modulation Research
- Main Research Peptides Store
- TB-500 for Sale – Tissue Repair Research Peptide
- BPC-157 for Sale – Healing Peptide Research Compound
Research use only. Not for human consumption.
Reviews
There are no reviews yet.